cilostazol has been researched along with Vascular Diseases in 4 studies
Vascular Diseases: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We review what we consider to be the top 12 advances in this field: the discovery of nitric oxide, the metabolic syndrome, new thrombophilic disorders, therapeutic angiogenesis, endoluminal treatment of chronic venous disease, and a variety of drugs, including sildenafil, cilostazol, low-molecular-weight heparins, oral direct thrombin inhibitors, clopidogrel, statins, and angiotensin-converting enzyme inhibitors and angiotensin-receptor blocking agents." | 4.82 | The top 12 advances in vascular medicine. ( Beckman, JA; Jaff, MR; Jang, J; Olin, JW; Rooke, T, 2004) |
| "Colchicine is a microtubule-destabilizing agent that may enhance the synthesis of cAMP." | 1.72 | Cardiovascular Protection Associated With Cilostazol, Colchicine, and Target of Rapamycin Inhibitors. ( Adeva-Andany, MM; Carneiro-Freire, N; Castro-Quintela, E; Fernández-Fernández, C; González-Lucán, M; Vila-Altesor, M, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adeva-Andany, MM | 1 |
| Fernández-Fernández, C | 1 |
| Carneiro-Freire, N | 1 |
| Castro-Quintela, E | 1 |
| Vila-Altesor, M | 1 |
| González-Lucán, M | 1 |
| Lee, CH | 1 |
| Hung, YJ | 1 |
| Shieh, YS | 1 |
| Chien, CY | 1 |
| Hsu, YJ | 1 |
| Lin, CY | 1 |
| Chiang, CF | 1 |
| Huang, CL | 1 |
| Hsieh, CH | 1 |
| Olin, JW | 1 |
| Jang, J | 1 |
| Jaff, MR | 1 |
| Beckman, JA | 1 |
| Rooke, T | 1 |
| Gao, L | 1 |
| Wang, F | 1 |
| Wang, B | 1 |
| Gong, B | 1 |
| Zhang, J | 1 |
| Zhang, X | 1 |
| Zhao, J | 1 |
1 review available for cilostazol and Vascular Diseases
| Article | Year |
|---|---|
The top 12 advances in vascular medicine.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cilostazol; Clopidogrel; Factor V; Heparin, Low-Molecular- | 2004 |
3 other studies available for cilostazol and Vascular Diseases
| Article | Year |
|---|---|
Cardiovascular Protection Associated With Cilostazol, Colchicine, and Target of Rapamycin Inhibitors.
Topics: Cilostazol; Colchicine; Coronary Artery Disease; Cyclic AMP; Diabetes Mellitus, Type 2; Humans; Musc | 2022 |
Cilostazol inhibits uremic toxin-induced vascular smooth muscle cell dysfunction: role of Axl signaling.
Topics: Animals; Axl Receptor Tyrosine Kinase; Cell Line; Cell Movement; Cell Survival; Cilostazol; Cresols; | 2017 |
Cilostazol protects diabetic rats from vascular inflammation via nuclear factor-kappa B-dependent down-regulation of vascular cell adhesion molecule-1 expression.
Topics: Animals; Cilostazol; Diabetes Mellitus, Experimental; Down-Regulation; Endothelium, Vascular; Gene E | 2006 |